Table 6 Investigator assessed best overall response
Best response according to medical judgment | Everolimus (N = 120), n (%) |
|---|---|
Complete response | 0 (0.0) |
Partial response | 81 (67.5) |
Stable disease | 35 (29.2) |
Progressive disease | 1 (0.8) |
Unknown | 3 (2.5) |
Best response according to medical judgment | Everolimus (N = 120), n (%) |
|---|---|
Complete response | 0 (0.0) |
Partial response | 81 (67.5) |
Stable disease | 35 (29.2) |
Progressive disease | 1 (0.8) |
Unknown | 3 (2.5) |